Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: Autoplaque is intended to provide an optimized non-invasive application to analyze coronary anatomy and pathology and aid in determining treatment paths from a set of Computed Tomography (CT) Angiographic images. Autoplaque 3.0 allows for standardized characterization of plaque and stenosis from DICOM image data (loaded from the local computer hard drive).
Scope: Exact FDA submission. The exact packet supports CT angiographic images and DICOM image data loaded from the local computer hard drive; the current generic protocol and quality wording is not retained.
Confirm scanner/model, protocol, series completeness and both software builds.
Field checked 2026-09-19 · FDA K212758: Autoplaque
Routing
Source context, not route validation: The exact-submission ACR model card explicitly references DICOM in the described input, output, or workflow; exact interfaces, versions, and local compatibility require confirmation.
Scope: Exact FDA submission. Interoperability terms explicitly reported in the exact-submission ACR model card; interface versions and local compatibility still require confirmation.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Field checked 2026-09-01 · Autoplaque 3.0 model card (K212758)
AI processing
Source context, not route validation: The exact FDA package describes Autoplaque as a workstation-based post-processing application that must be installed on a suitable commercial computer platform and can run on Windows or Mac computer platforms. Current hosting, data flow, and commercial configuration require vendor confirmation.
Scope: Exact FDA submission. Packet wording: "Autoplaque is a workstation-based post processing application." … "Autoplaque must be installed on a suitable commercial computer platform.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
Confirm processing location, queue ownership, exclusions and exact AI build.
Field checked 2026-11-14 · FDA K212758: Autoplaque
Returned objects
Source context, not route validation: The AI model outputs automated vessel, plaque, and lumen segmentation with quantitative measurements including: total plaque volume, calcified plaque volume (CP volume), non-calcified plaque volume (NCP volume), low-density non-calcified plaque volume (LD-NCP volume), plaque burden metrics, plaque composition metrics, diameter stenosis, area stenosis, remodeling index, plaque length, contrast density difference, minimal luminal diameter (MLD), minimum luminal area (MLA), vessel profile measurements, and lumen profile measurements. Results are displayed in MPR, curved MPR, and straightened MPR views.
Scope: Exact FDA submission. Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Field checked 2026-09-19 · FDA K212758: Autoplaque
Viewer/worklist/report
Unresolved route: The AI model outputs automated vessel, plaque, and lumen segmentation with quantitative measurements including: total plaque volume, calcified plaque volume (CP volume), non-calcified plaque volume (NCP volume), low-density non-calcified plaque volume (LD-NCP volume), plaque burden metrics, plaque composition metrics, diameter stenosis, area stenosis, remodeling index, plaque length, contrast density difference, minimal luminal diameter (MLD), minimum luminal area (MLA), vessel profile measurements, and lumen profile measurements. Results are displayed in MPR, curved MPR, and straightened MPR views.
Scope: Exact FDA submission. Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Field checked 2026-09-19 · FDA K212758: Autoplaque
Support owner
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
No tests below have been performed or accepted.